Lightnews — Scholar-powered news

jpmkane.bsky.social @jpmkane.bsky.social · Aug 8

Congratulations Jon and colleagues!

jpmkane.bsky.social @jpmkane.bsky.social · Jul 17

We are counting down for #AAIC25 and to catch up with our #LBDPIA members in person 😍 As we wait patiently, we prepared a webpage for you to find us, check out our work and join our team:

sites.google.com/view/lbdpia-...

jpmkane.bsky.social @jpmkane.bsky.social · Jul 15

I’d really like to applaud your almost single-handed attempts to reintroduce “wick” into the modern lexicon. When one of your characters said it on a R4 play I heard it absolutely made my day

Doodle is the simplest way to schedule meetings with clients, colleagues, or friends. Find the best time for one-to-ones and team meetings with our user-friendly calendar tool. Get started today!

jpmkane.bsky.social @jpmkane.bsky.social · Jul 14

🎓 Are you an early-career researcher in #LewyBodyDementia? Join us at Lewy Connect, hosted by LBDA at #AAIC2025!
🗓️ July 29, 6–8pm
📍 InterContinental Toronto Centre
🔗 Network, meet LBD leaders, build your career!

RSVP now—space is limited! 👇
doodle.com/sign-up-shee...

Doodle

doodle.com

Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review - Alzheimer's Research & Therapy

jpmkane.bsky.social @jpmkane.bsky.social · May 27

There’s a lot of DLB research happening, but what are we actually asking people with DLB and their care partners? Which perspectives are we missing?

@qubelfastofficial.bsky.social PhD candidate Paula Sinéad Donnelly leads this insightful scoping review👇

alzres.biomedcentral.com/articles/10....

Background Dementia with Lewy bodies (DLB) is associated with specific challenges, including heterogeneity in clinical presentation and a less favourable prognosis relative to other dementia subtypes....

alzres.biomedcentral.com

jpmkane.bsky.social @jpmkane.bsky.social · May 27

Last week @qubelfastofficial.bsky.social we were delighted to host Dr Yuto Satake from Osaka University and @ucl.ac.uk to discuss his work on AD & DLB biomarkers, very late onset psychosis and tackling loneliness with SoTa the robot. Come back soon Yuto!

jpmkane.bsky.social @jpmkane.bsky.social · May 12

We were joined today by attendees from FORTY-SIX countries!
🇦🇫 🇦🇽 🇩🇿 🇦🇴 🇦🇷 🇦🇿 🇧🇷 🇧🇳 🇧🇫 🇨🇦 🇨🇱 🇨🇳 🇨🇴 🇨🇿 🇪🇬 🇬🇪 🇩🇪 🇬🇭 🇬🇷 🇭🇰 🇮🇳 🇮🇩 🇮🇪 🇰🇪 🇲🇹 🇲🇺 🇲🇲 🇳🇬 🇵🇰 🇵🇪 🇵🇭 🇸🇦 🇸🇬 🇿🇦 🇪🇸 🇱🇰 🇸🇪 🇹🇼 🇹🇭 🇹🇹 🇹🇳 🇹🇷 🇬🇧 🇺🇸 🇻🇪 🇻🇳

jpmkane.bsky.social @jpmkane.bsky.social · May 12

Fantastic to host today's @istaart.bsky.social #LBDPIA Clinical Case Review webinar, with presentations from Dra. Cecilia Fernández & Drs Agnew, Garcia & Barton from @belfasttrust.bsky.social.

Tomorrow's webinar will discuss the same cases in Spanish - register here istaart.alz.org/events/item/...

screenshot of a zoom webinar with five doctors speaking

1 2

Reposted

Ece Bayram @ecebayram.bsky.social · Apr 8

📢📢 @istaart.bsky.social #DemenciaConCuerposDeLewy Seminario de Casos Clínicos en español tendrá lugar el 13 de mayo,10am US CT📢📢 #LBDPIA vicepresidente
@frodriguezporcel.bsky.social moderará con oradores fabulosos Ceci Fernandez,Ruth Agnew&Fernando Garcia
Regístrate!
alz-org.zoom.us/webinar/regi...

2 3

jpmkane.bsky.social @jpmkane.bsky.social · May 12

Fantastic to host today's @istaart.bsky.social #LBDPIA Clinical Case Review webinar, with presentations from Dra. Cecilia Fernández & Drs Agnew, Garcia & Barton from @belfasttrust.bsky.social.

Tomorrow's webinar will discuss the same cases in Spanish - register here istaart.alz.org/events/item/...

3 4

jpmkane.bsky.social @jpmkane.bsky.social · May 12

Genial haber sido anfitrión del seminario web de Revisión de Casos Clínicos @istaart.bsky.social #LBDPIA de hoy con Dra. Cecilia Fernández y Drs. Agnew, Garcia y Barton de @belfasttrust.bsky.social.

Regístrate aquí para nuestro seminario web en español mañana: istaart.alz.org/events/item/...

Reposted

Lincoln Michel @thelincoln.bsky.social · Feb 25

Don't let anyone tell you that you can't live your dreams

News article with this passage highlighted: "who asked not to be identified because she has always wanted to be an anonymous source"

1 300 1.7K

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

Perhaps the larger problem is that when you establish memory clinics galore that many parts of the system don’t adequate look beyond memory

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

I don’t know to be honest. You would assume that, in the most part, they’re doing neuro exams either - so there would be a knock on effect on sensitivity. I do think that quality of care is too often conflated with diagnostic rates - and it is in the former that the MDT comes into its own

2 2

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

Could you expand on what you mean by “less skilled clinical staff”?

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

I do think “sketchy” is a bit harsh. Every specialty & service has its blind spots. Fluctuations tricky at best of times & RBD requires bed partner informant for recognition. in routine practice - especially in older populations - there is no shortage of comorbidities& complicating factors

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

Parkinsonism not necessarily late-emerging. And DaTScans not 100% necessary in all cases but crucial in some. The failure to detect Parkinsonism or have an abnormal DaT can be the difference between an AD diagnosis and a DLB one.

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

Patients with DLB are certainly not all referred to neuro - when you look for the symptoms in “memory clinic” populations, they’re there…

jpmkane.bsky.social @jpmkane.bsky.social · Feb 11

It’s because psychiatry led services are much less likely to do a neuro exam and therefore more likely to miss Parkinsonism. Anecdotally may be less likely to detect fluctuations or RBD. Access to DaTScans varies a lot geographically and so do clinicians’ diagnostic thresholds

www.cambridge.org

5 2

Reposted

ISTAART @istaart.bsky.social · Jan 23

ISTAART is on Bluesky! Follow us as we discuss the latest in research and treatment and make connections to grow the global dementia science community.

7 11

jpmkane.bsky.social @jpmkane.bsky.social · Dec 5

#AAIC25 is Canada-bound 🇨🇦

Abstract and session proposals can now be submitted at aaic.alz.org

This is a flyer for AAIC25 in Toronto. "Put a spotlight on your research" - abstract and session proposals due Jan 27th at alz.org/AAIC2025

jpmkane.bsky.social @jpmkane.bsky.social · Nov 17

@kaanthanj.bsky.social the profile pic 😂😂😂

jpmkane.bsky.social @jpmkane.bsky.social · Nov 17

@carlaabdelnour.bsky.social bienvenida Carla!

jpmkane.bsky.social @jpmkane.bsky.social · Nov 17

@rikossenkoppele.bsky.social welcome Rik!

jpmkane.bsky.social @jpmkane.bsky.social · Nov 14

“Well, here we all are now, all the lads”.